Liver Diseases  >>  sirolimus  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sirolimus / Generic mfg.
NCT00467194: Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Checkmark P1 data: (rapamycin + bevacizumab)
Dec 2012 - Dec 2012: P1 data: (rapamycin + bevacizumab)
Completed
1
27
RoW
Rapamycin, Bevacizumab
National Cancer Centre, Singapore
Liver Cancer
05/11
 
NCT02145559: A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors

Completed
1
24
US
Metformin XR, Delayed Metformin, Sirolimus
University of Chicago
Breast Neoplasms, Lung Neoplasms, Cancer of Liver, Lymphoma, Cancer of Kidney
11/16
07/18

Download Options